5,493
Views
90
CrossRef citations to date
0
Altmetric
Review Article

Vitamin D and living in northern latitudes—an endemic risk area for vitamin D deficiency

& (Professor)
Pages 164-178 | Received 23 May 2007, Accepted 22 Feb 2008, Published online: 01 Jun 2008

References

  • Feldman D, Pike JW, Glorieux F editors. Vitamin D. 2nd ed. San Diego, CA: Academic Press; 2006.1952 pp.
  • Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 2004; 29: 664–673.
  • Vieth R. Simple method for determining specific binding capacity of vitamin D-binding protein and its use to calculate the concentration of “free” 1,25-dihy-droxyvitamin D. Clin Chem 1994; 40: 435–441.
  • Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005; 289: F8–F28.
  • Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest 1986; 78: 1296–1301.
  • Mackey SL, Heymont JL, Kronenberg HM, Demay MB. Vitamin D receptor binding to the negative human parathyroid hormone vitamin D response element does not require the retinoid x receptor. Mol Endocrinol 1996; 10: 298–305.
  • Carlberg C, Seuter S. The Vitamin D Receptor. Dermatol Clin 2007; 25: 515–523.
  • Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005; 26: 662–687.
  • Carlberg C. Molecular basis of the selective activity of vitamin D analogues. J Cell Biochem 2003; 882: 274–281.
  • Masuda S, Jones G. Promise of vitamin D analogues in the treatment of hyperproliferative conditions. Mol Cancer Ther 2006; 5: 797–808.
  • Need AG. Bone resorption markers in vitamin D insufficiency. Clinica Chimica Acta 2006; 368: 48–52.
  • Consensus Development Conference: prophylaxis and treatment of osteoporosis. Am J Med 1991 90: 107–110.
  • Vieth R. The role of vitamin Din the prevention of osteoporosis. Ann Med 2005; 37: 278–285.
  • Sambrook P, Cooper C. Osteoporosis. Lancet 2006; 367: 2010–2018
  • Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts and prospects. J Clin Invest 2005; 115: 3318–3325.
  • Lane NE. Epidemiology, etiology and diagnosis of osteoporosis. Am J Obstet Gynecol 2006;194(2 Suppl): S3–S11.
  • Roy DK, Pye SR, Lunt M, O’Neill TW, Todd C, Raspe H et al. Falls explain betweencenter differences in the incidence of limb fracture across Europe. Bone 2002; 31: 712–717.
  • Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006; 17: 1726–1733.
  • Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a metaanalysis of randomized controlled trials. JAMA 2005; 293: 2257–2264.
  • Boonen S, Vanderschueren D, Haentjens P, Lips P. Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update. J Intern Med 2006; 259: 539–552.
  • Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 2004; 19: 370–378.
  • Lilliu H, Pamphile R, Chapuy M, Schulten J, Arlot M, Meunier PJ. Calcium-vitamin D3 supplementation is cost-effective in hip fractures prevention. Maturitas 2003; 44: 299–305.
  • Holick M F. Vitamin D: importance in the prevention of cancers, type I diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004; 79: 362–371.
  • Mosekilde L. Vitamin D and the elderly. Clin Endocrinol (Oxf) 2005; 62: 265–281.
  • Cantorna MT. Vitamin D and its role in immunology: multiple sclerosis and inflammatory bowel disease. Prog Biophys Mol Biol 2006; 92: 60–64.
  • Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3. Cancer Epidemiol Biomarkers Prey 19987:391–395.
  • Tangpricha V, Flanagan JN, Whitlatch LW, Tseng CC, Chen TC, Holt PR et al. 25-hydroxyvitamin D-1 [alpha]- hydroxylase in normal and malignant colon tissue. Lancet 2001; 357: 1673–1674.
  • Mawer E, Hayes M, Heys S, Davies M, White A, Stewart MF, et al. Constitutive synthesis of 1,25-dihy-droxyvitamin D3 by a human small cell lung cancer cell line. J Clin Endocrinol Metab 1994; 79: 554–560.
  • Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 2000 ; 11: 847–852.
  • Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980; 9: 227–231.
  • Freedman DM, Dosemeci M, McGlynn K. Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med 2002; 59: 257–262.
  • Grant WB, Garland CF. The association of solar ultra-violet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 2006; 26: 2687–2699.
  • Zhuang S, Burnstein KL. Antiproliferative Effect of 1α,25-Dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent GI accumulation. Endocrinology 1998; 139: 1197–1207.
  • Blutt SE, Allegretto EA, Pike JW, Weigel NL. 1,25-Dihydroxyvitamin D3 and 9-cisretinoic acid act syner-gistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in GI. Endocrinology 1997; 138: 1491–1497.
  • Blutt SE, McDonnell TJ, Polek TC, Weigel NL. Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of BcI-2. Endocrinology 2000; 141: 10–17.
  • Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested casecontrol study in the Nordic countries. Int J Cancer 2004; 108: 104–108.
  • Pence BC, Buddingh F. Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis 1988; 9: 187–190.
  • Kawaura A, Tanida N, Sawada K, Oda M, Shimoyama T. Supplemental administration of 1 alpha-hydroxyvitamin D3 inhibits promotion by intrarectal instillation of lithocholic acid in N-methyl-N-nitrosoureainduced colonic tumorigenesis in rats. Carcinogenesis 1989; 10: 647–649.
  • Park S, Murphy S, Wilkens L, Nomura A, Henderson B, Kolonel L. Calcium and vitamin d intake and risk of colorectal cancer: the multiethnic cohort study. Am J Epidemiol 2007; 165: 784–793.
  • Hyppönen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type I diabetes: a birth-cohort study. Lancet 2001; 358: 1500–1503.
  • Vitamin D supplement in early childhood and risk for type 1 (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia 1999; 42: 51–54.
  • Pozzilli P, Manfrini S, Crino A, et al. Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type I diabetes. Horm Metab Res 2005; 37: 680–683.
  • Littorin B, Blom P, Scholin A, Arnqvist HJ, Blohmé G, Bolinder J et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type I diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006; 49: 2847–2852.
  • Viskari H, Kondrashova A, Koskela P, Knip M, Hyöty H. Circulating vitamin D concentrations in two neighboring populations with markedly different incidence of type I diabetes. Diabetes Care 2006; 29: 1458–1459.
  • VanAmerongen BM, Dijkstra CD, Lips P, Polman CH. Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr 2004; 58: 1095–1109.
  • Kampman MT, Wilsgaard T, Mellgren SI. Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol 2007; 254: 471–477.
  • Lamberg-Allardt C. Vitamin D in foods and as supplements. Prog Biophys Mol Biol 2006; 92: 33–38.
  • Outila TA, Karkkainen MU, Seppanen RH, Lamberg-Allardt CJ. Dietary intake of vitamin D in premenopausal, healthy vegans was insufficient to maintain concentrations of serum 25-hydroxyvitamin D and intact parathyroid hormone within normal ranges during the winter in Finland. J Am Diet Assoc 2000; 100: 434–441.
  • Laaksi IT, Ruohola JP, Ylikomi TJ, Auvinen A, Haataja RI, Pihlajamaki HK, et al. Vitamin D fortification as public health policy: significant improvement in vitamin D status in young Finnish men. Eur J Clin Nutr 2006; 60: 1035–1038.
  • Piirainen T, Laitinen K, Isolauri E. Impact of national fortification of fluid milks and margarines with vitamin D on dietary intake and serum 25-hydroxyvitamin D concentration in 4-year-old children. Eur J Clin Nutr 2007; 61: 123–128.
  • Calvo MS, Whiting SJ, Barton CN. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr 2004; 80: 17105–1716.
  • Lamberg-Allardt CJ, Viljakainen H et al. Followup study on the vitamin D status in the Finnish population 2002 and 2004. Helsinki: Ministry of Social Affairs and Health; 2006.49 pp.
  • Holick MF. Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol 2006; 92: 49–59.
  • Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004; 89: 5387–5391.
  • Whiting SJ, Calvo MS. Dietary recommendations for vitamin D: a critical need for functional end points to establish an estimated average requirement. J Nutr 2005; 135: 304–309.
  • Hollis BW. Circulating 25-Hydroxyvitamin D Levels Indicative of Vitamin D Sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005; 135: 317–322.
  • Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84: 18–28.
  • Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, Heaney RP et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007; 85: 649–650.
  • Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: A global perspective of current status. J Nutr 2005; 135: 310–316.
  • Lips P. Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 2004;89–90:611–614.
  • Vieth R. Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards. J Nutr 2006; 136: 1117–1122.
  • Lamberg-Allardt CJ, Outila TA, Karkkainen MU, Rita HJ, Valsta LM. Vitamin D deficiency and bone health in healthy adults in Finland: could this be a concern in other parts of Europe? J Bone Miner Res 2001; 16: 2066–2073.
  • Samuelson G. Dietary habits and nutritional status in adolescents over Europe. An overview of current studies in the Nordic countries. Eur J Clin Nutr 2000; 54 Suppl 1: S21–28.
  • Jorde R, Bonaa KH. Calcium from dairy products, vitamin D intake, and blood pressure: the Tromso Study. Am J Clin Nutr 2000; 71: 1530–1535.
  • Rapuri PB, Kinyamu HK, Gallagher JC, Haynatzka V. Seasonal changes in calciotropic hormones, bone markers, and bone mineral density in elderly women. J Clin Endocrinol Metab 2002; 87: 2024–2032.
  • Calvo MS, Whiting SJ. Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement use. Nutr Rev 2003; 61: 107–113.
  • Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006; 116: 2062–2072.
  • Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006; 81: 353–373.
  • Hyppönen E, Power C. Hypovitaminosis D in British adults at age 45 years: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007; 85: 860–868.
  • Harris S, Dawson-Hughes B. Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. Am J Clin Nutr 1998; 67: 1232–1236.
  • Maxwell JD. Seasonal variation in vitamin D. Proc Nutr Soc 1994; 53: 533–543.
  • Andersen R, Molgaard C, Skovgaard LT, Brot C, Cashman KD, Chabros E, et al. Teenage girls and elderly women living in northern Europe have low winter vitamin D status. Eur J Clin Nutr 2005; 59: 533–541.
  • Outila TA, Karkkainen MU, Lamberg-Allardt CJ. Vitamin D status affects serum parathyroid hormone concentrations during winter in female adolescents: associations with forearm bone mineral density. Am J Clin Nutr 2001; 74: 206–210.
  • Gerdhem P, Mallmin H, Akesson K, Obrant KJ. Seasonal variation in bone density in postmenopausal women. J Clin Densitom 2004; 7: 93–100.
  • Brustad M, Alsaker E, Engelsen O, Aksnes L, Lund E. Vitamin D status of middleaged women at 65–71 degrees N in relation to dietary intake and exposure to ultraviolet radiation. Public Health Nutr 2004; 7: 327–335.
  • Brustad M, Sandanger T, Wilsgaard T, Aksnes L, Lund E. Change in plasma levels of vitamin D after consumption of codliver and fresh codliver oil as part of the traditional north Norwegian fish dish “Molje.” Int J Circumpolar Health 2003; 62: 40–53.
  • Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 2001; 86: 1212–1221.
  • Ovesen L, Andersen R, Jakobsen J. Geographical differences in vitamin D status, with particular reference to European countries. Proc Nutr Soc 2003; 62: 813–821.
  • Kauppinen-Makelin R, Tahtela R, Löyttyniemi E, Kärkkäinen J, Välimäki MJ. A high prevalence of hypovitaminosis D in Finnish medical in-and outpatients. J Intern Med 2001; 249: 559–563.
  • Brox J, Bjornstad E, Olaussen K. Hemoglobin, iron, nutrition and life-style among adolescents in a coastal and an inland community in northern Norway. Int J Circumpolar Health 2003; 62: 130–141.
  • MacLaughlin J, Holick M F. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985; 76: 1536–1538.
  • Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, and solar ultraviolet. Lancet 1989; 2: 1104–1105.
  • Ebeling PR, Sandgren ME, Di Magno EP, Lane AW, De-Luca HF, Riggs BL. Evidence of an agerelated decrease in intestinal responsiveness to vitamin D: relationship between serum 1,25-dihydroxyvitamin D3 and intestinal vitamin D receptor concentrations in normal women. J Clin Endocrinol Metab 1992; 75: 176–182.
  • Carlin AM, Rao DS, Meslemani AM, Genaw JA, Parikh NJ, Levy S et al. Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery. Surg Obes Relat Dis 2006; 2: 98–103.
  • Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick M F. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690–693.
  • Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842–856.
  • Adams JS, Lee G. Gains in bone mineral density with resolution of vitamin D intoxication. Ann Intern Med 1997; 127: 203–206.
  • Marriott BM. Vitamin D supplementation: A word of caution. Ann Intern Med 1997; 127: 231–233.
  • Weaver CM, Fleet JC. Vitamin D requirements: current and future. Am J Clin Nutr 2004;80(6 Suppl): 1735S–17395.
  • Narang NK, Gupta RC, Jain MK. Role of vitamin Din pulmonary tuberculosis. J Assoc Physicians India 1984; 32: 185–188.
  • Vieth R, Chan PR, MacFarlane G D. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001; 73: 288–294.
  • Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 2007; 85: 6–18.
  • Nordic Council of Ministers. Nordic Nutrition Recommendations 2004. 4th ed. Arhus: Nordic Council of Ministers; 2004.21 pp.
  • Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. Washington, DC: National Academy Press; 1997.448 pp.
  • Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992; 327: 1637–1642.
  • Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997; 337: 670–676.
  • Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003; 326: 469.
  • Meyer HE, Smedshaug GB, Kvaavik E, Falch JA, Tverdal A, Pedersen JI. Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial. J Bone Miner Res 2002; 17: 709–715.
  • Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a shortterm vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 2000; 15: 1113–1118.
  • Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. Vitamin D supplementation and fracture incidence in elderly persons: a randomized, placebo-controlled clinical trial. Ann Intern Med 1996; 124: 400–406.
  • Danish Institute for Food and Veterinary Research; 2005 [cited 2007 Jan 2]. Available from: http://www.foodcomp.dk/fcdb_complist.asp.
  • Kansanterveyslaitos; 2007 [cited 2007 Jan 2]. Available from: http://www.fineli.fi/topfoods.php?lang=fi.
  • Rejnmark L, Jorgensen ME, Pedersen MB, Hansen JC, Heickendorff L, Lauridsen AL, et al. Vitamin D insufficiency in Greenlanders on a westernized fare: ethnic differences in calcitropic hormones between Greenlanders and Danes. Calcif Tissue Int 2004; 74: 255–263.